RESPOND TO PREVENT: Project Description

Community pharmacies are ideally positioned to address the opioid epidemic, as they have a significant amount of face time with both people who have been prescribed opioids and people who access pharmacies for sterile syringes. Pharmacies are expected to provide education to patients on how to safely use and store opioids, minimize opioids risks, and use naloxone.

The RESPOND TO PREVENT training program and toolkit address both safe opioid and naloxone dispensing at the pharmacy-level to reduce opioid-related harms for all individuals at risk of overdose.

The RESPOND TO PREVENT program and toolkit were part of a large multi state study funded by the National Institutes of Health carried out in community pharmacies.

The research team investigated whether the program positively changed how pharmacists and pharmacy technicians feel about naloxone, how they discussed it with patients, and measured how often they provide naloxone. The goal of the RESPOND TO PREVENT program and toolkit was to improve access to naloxone in community pharmacies by improving attitudes about and facilitate provision of this life saving medication in pharmacies.


Traci Green, PhD, MSc
Primary Investigator
Brandeis University

Jeffrey Bratberg, PharmD
Co-Investigator & Academic Detailing Lead
University of Rhode Island

Adriane Irwin, PharmD, MS, BCACP, CDE
Co-Investigator & Oregon Academic Detailing Lead
Oregon State University

Dan Hartung, PharmD, MPH
Oregon State University/Oregon Health & Science University

Ryan Hansen, PharmD, PhD
Kelley-Ross Pharmacy Group

Alexander Walley, MD, MSc
Co-Investigator & Subject Matter Expert
Boston University School of Medicine

Caleb Banta-Green, PhD
University of Washington